Tag: Editas Medicine

  • Halted: CRISPR Could Explode on US FDA Decision

    Halted: CRISPR Could Explode on US FDA Decision

    Keep an eye on CRISPR Therapeutics (CRSP). At the moment, it’s halted. But it could get explosive if the U.S. Food and Drug Administration’s (FDA) Cellular, Tissue, and Gene Therapies Advisory Committee green lights the company’s Biologics License Application (BLA) for exagamglogene autotemcel (exa-cel) for the treatment of sickle cell disease (SCD) in people ages…